SelectQuote, Inc. (NYSE:SLQT) Shares Bought by Marshall Wace LLP

Marshall Wace LLP grew its position in SelectQuote, Inc. (NYSE:SLQT - Free Report) by 48.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,052,239 shares of the company's stock after purchasing an additional 341,981 shares during the quarter. Marshall Wace LLP owned about 0.61% of SelectQuote worth $3,914,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Bank of Montreal Can raised its position in shares of SelectQuote by 1.3% in the fourth quarter. Bank of Montreal Can now owns 202,675 shares of the company's stock worth $754,000 after acquiring an additional 2,674 shares during the period. Invesco Ltd. raised its position in shares of SelectQuote by 1.7% in the fourth quarter. Invesco Ltd. now owns 225,293 shares of the company's stock worth $838,000 after acquiring an additional 3,776 shares during the period. Rhumbline Advisers raised its position in shares of SelectQuote by 2.6% in the fourth quarter. Rhumbline Advisers now owns 209,743 shares of the company's stock worth $780,000 after acquiring an additional 5,235 shares during the period. SG Americas Securities LLC raised its position in shares of SelectQuote by 10.5% in the fourth quarter. SG Americas Securities LLC now owns 91,508 shares of the company's stock worth $340,000 after acquiring an additional 8,660 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in shares of SelectQuote by 0.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,191,701 shares of the company's stock worth $4,433,000 after acquiring an additional 10,038 shares during the period. 34.59% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Noble Financial raised shares of SelectQuote to a "strong-buy" rating in a research note on Wednesday, February 12th.

SelectQuote Stock Down 2.7 %

Shares of NYSE:SLQT traded down $0.09 on Tuesday, hitting $3.29. 712,810 shares of the company's stock were exchanged, compared to its average volume of 1,360,918. The firm's 50-day moving average is $3.61 and its 200 day moving average is $3.46. The company has a market capitalization of $566.35 million, a PE ratio of -36.56 and a beta of 1.25. SelectQuote, Inc. has a 1-year low of $1.48 and a 1-year high of $6.86. The company has a debt-to-equity ratio of 2.10, a quick ratio of 6.36 and a current ratio of 6.36.

SelectQuote (NYSE:SLQT - Get Free Report) last posted its earnings results on Monday, February 10th. The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.21. SelectQuote had a negative return on equity of 4.38% and a negative net margin of 0.95%. Sell-side analysts predict that SelectQuote, Inc. will post -0.07 EPS for the current year.

Insider Buying and Selling at SelectQuote

In other SelectQuote news, insider Sarah Taylor Anderson sold 50,000 shares of the business's stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $5.44, for a total transaction of $272,000.00. Following the sale, the insider now directly owns 1,166 shares in the company, valued at approximately $6,343.04. The trade was a 97.72 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 11.40% of the stock is owned by company insiders.

About SelectQuote

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.